Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Glucose Metabolic Trapping in Mouse Arteries: Nonradioactive Assay of Atherosclerotic Plaque Inflammation Applicable to Drug Discovery

  • Richard G. Conway,

    Affiliation Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • Eyassu Chernet,

    Affiliation Psychiatric Disorders, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • David C. De Rosa,

    Affiliation ImmunoModulation, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • Robert J. Benschop,

    Affiliation ImmunoModulation, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • Anne B. Need,

    Affiliation Translational Science, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • Emily C. Collins,

    Affiliation Translational Science, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • James S. Bean,

    Affiliation Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • J. Michael Kalbfleisch,

    Affiliation Translational Science, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯
  • Mark D. Rekhter

    rekhter_mark@lilly.com

    Affiliation Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.